Trigone Pharma

Trigone Pharma is a clinical-stage pharmaceutical company focused on developing innovative and safe local treatments for urinary tract diseases. Trigone Pharma is dedicated to improving the lives of patients suffering from bladder diseases with significant unmet medical needs. The company’s primary address is located at 15 HaTidahar Street, Raanana, IL.

Utilizing a highly innovative delivery system for the sustained release of drugs into the urinary bladder, Trigone Pharma's localized therapies provide continuous treatment for up to several weeks, marking a significant advancement in urology. Trigone Pharma's approach aims to revolutionize patient care by offering more effective and convenient treatment options.

Currently, Trigone Pharma has multiple products in development. The lead product targets the treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS) and is undergoing clinical trials. Additionally, Trigone Pharma is developing a treatment for BCG-Refractory Non-Muscle Invasive Bladder Cancer (NMIBC), which is currently in the preclinical stage. We invite the manager of Trigone Pharma to create a customized and exclusive company showcase and product listing on our platform.